UY36399A - Compuestos aromáticos sustituidos y composiciones farmacéuticas para la autoreparación y regeneración del tejido - Google Patents

Compuestos aromáticos sustituidos y composiciones farmacéuticas para la autoreparación y regeneración del tejido

Info

Publication number
UY36399A
UY36399A UY0001036399A UY36399A UY36399A UY 36399 A UY36399 A UY 36399A UY 0001036399 A UY0001036399 A UY 0001036399A UY 36399 A UY36399 A UY 36399A UY 36399 A UY36399 A UY 36399A
Authority
UY
Uruguay
Prior art keywords
tissue
self
regeneration
fabric
treatment
Prior art date
Application number
UY0001036399A
Other languages
English (en)
Inventor
Gagnon Lyne
Laurin Pierre
Original Assignee
Prometic Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prometic Biosciences Inc filed Critical Prometic Biosciences Inc
Publication of UY36399A publication Critical patent/UY36399A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • C07C57/32—Phenylacetic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/52—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen
    • C07C57/58—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
    • C07C59/52—Unsaturated compounds containing hydroxy or O-metal groups a hydroxy or O-metal group being bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/84—Unsaturated compounds containing keto groups containing six membered aromatic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

En la presente se describen compuestos de la fórmula I o sales farmacéuticamente aceptables de estos o combinaciones de estos,sí como sus usos. Estos usos incluyen promover la autoreparación del tejido o regeneración del tejido de un órgano, estimular la generación de crecimiento tisular, modular (p. ej., aumentar) el nivel de un marcador de reparación del tejido, tratar una lesión física en un órgano, tejido o célula,promover la cicatrización, así como aplicaciones antienvejecimiento. También se describen composiciones, métodos, kits y usos correspondientes.
UY0001036399A 2014-11-12 2015-11-12 Compuestos aromáticos sustituidos y composiciones farmacéuticas para la autoreparación y regeneración del tejido UY36399A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201462078704P 2014-11-12 2014-11-12

Publications (1)

Publication Number Publication Date
UY36399A true UY36399A (es) 2016-06-30

Family

ID=55953490

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001036399A UY36399A (es) 2014-11-12 2015-11-12 Compuestos aromáticos sustituidos y composiciones farmacéuticas para la autoreparación y regeneración del tejido

Country Status (19)

Country Link
US (3) US10391073B2 (es)
EP (1) EP3217968A4 (es)
JP (1) JP6720169B2 (es)
KR (1) KR20170072352A (es)
CN (1) CN107106526B (es)
AR (1) AR102634A1 (es)
AU (2) AU2015345943B2 (es)
BR (1) BR112017009899A2 (es)
CA (1) CA2967499C (es)
IL (1) IL252221B (es)
MX (1) MX2017006281A (es)
MY (1) MY187515A (es)
PH (1) PH12017500856A1 (es)
RU (1) RU2728782C2 (es)
SG (1) SG11201703741TA (es)
TW (1) TWI723967B (es)
UY (1) UY36399A (es)
WO (1) WO2016074068A1 (es)
ZA (1) ZA201703579B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI689489B (zh) * 2013-03-15 2020-04-01 英商邊緣生物科技有限公司 用於治療肺纖維化、肝纖維化、皮膚纖維化及心臟纖維化之經取代之芳族化合物
AU2015345943B2 (en) * 2014-11-12 2020-03-19 Liminal Biosciences Limited Substituted aromatic compounds and pharmaceutical compositions for tissue self-repair and regeneration

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2289417C1 (ru) * 2005-04-15 2006-12-20 Равиль Шамилевич Мирхайдаров Способ биологического омоложения кожи
EP1953222A1 (en) * 2007-01-24 2008-08-06 Boehringer Ingelheim Pharma GmbH & Co. KG Improvement of cell growth
AU2010244930B2 (en) * 2009-05-04 2016-07-28 Liminal Biosciences Limited Substituted aromatic compounds and pharmaceutical uses thereof
TWI458481B (zh) * 2009-05-04 2014-11-01 Prometic Biosciences Inc ３－戊基苯乙酸的鹽及其藥學用途
ES2351005B1 (es) * 2009-07-10 2011-11-18 Consejo Superior De Investigaciones Científicas (Csic) Uso de anhidrasa carbónica ii para la elaboración de un medicamento.
JP6055771B2 (ja) 2010-10-27 2016-12-27 プロメティック・ファーマ・エスエムティ・リミテッドＰｒｏｍｅｔｉｃ Ｐｈａｒｍａ Ｓｍｔ Ｌｉｍｉｔｅｄ カルボン酸フェニルケトン化合物およびその薬学的使用
MX365807B (es) * 2010-10-27 2019-06-14 Prometic Pharma Smt Ltd Compuestos y composiciones para el tratamiento del cáncer.
JP5388233B2 (ja) * 2011-01-19 2014-01-15 富士ソフト株式会社 再生軟骨の軟骨特性を評価する方法
MX2014001623A (es) * 2011-08-10 2015-03-09 Digna Biotech Sl Uso de la cardiotofina-1 para el tratamiento de enfermedades renales.
TWI689490B (zh) * 2013-03-15 2020-04-01 英商邊緣生物科技有限公司 用於治療纖維化之經取代之芳族化合物及相關方法
TWI689489B (zh) * 2013-03-15 2020-04-01 英商邊緣生物科技有限公司 用於治療肺纖維化、肝纖維化、皮膚纖維化及心臟纖維化之經取代之芳族化合物
AU2015330643B2 (en) 2014-10-10 2020-05-14 Liminal Biosciences Limited Substituted aromatic compounds and pharmaceutical compositions for the prevention and treatment of diabetes
SG11201702868VA (en) 2014-10-10 2017-05-30 Prometic Pharma Smt Ltd Substituted aromatic compounds and pharmaceutical compositions for the prevention and treatment of osteoporosis
AU2015345943B2 (en) * 2014-11-12 2020-03-19 Liminal Biosciences Limited Substituted aromatic compounds and pharmaceutical compositions for tissue self-repair and regeneration

Also Published As

Publication number Publication date
US10391073B2 (en) 2019-08-27
AU2020204112B2 (en) 2021-10-21
CN107106526B (zh) 2021-05-28
EP3217968A1 (en) 2017-09-20
AU2020204112A1 (en) 2020-07-09
TW201618764A (zh) 2016-06-01
AU2015345943A1 (en) 2017-06-01
KR20170072352A (ko) 2017-06-26
ZA201703579B (en) 2018-08-29
TWI723967B (zh) 2021-04-11
US20210085626A1 (en) 2021-03-25
PH12017500856A1 (en) 2017-11-06
MX2017006281A (es) 2017-08-14
JP2017533928A (ja) 2017-11-16
CA2967499C (en) 2023-01-17
CN107106526A (zh) 2017-08-29
US20170312237A1 (en) 2017-11-02
RU2017120401A3 (es) 2019-06-06
RU2017120401A (ru) 2018-12-13
WO2016074068A1 (en) 2016-05-19
IL252221B (en) 2022-04-01
US20200078324A1 (en) 2020-03-12
RU2728782C2 (ru) 2020-07-31
IL252221A0 (en) 2017-07-31
MY187515A (en) 2021-09-24
BR112017009899A2 (pt) 2018-01-16
SG11201703741TA (en) 2017-06-29
AU2015345943B2 (en) 2020-03-19
EP3217968A4 (en) 2018-06-20
CA2967499A1 (en) 2016-05-19
US10869849B2 (en) 2020-12-22
AR102634A1 (es) 2017-03-15
JP6720169B2 (ja) 2020-07-08

Similar Documents

Publication Publication Date Title
CL2020000501A1 (es) Inhibidores de la ectonucleótido pirofosfatasa-fosfodiesterasa 1 (enpp1) y usos de los mismos.
DOP2019000168A (es) Compuestos de amino-triazolopiridina y su uso en el tratamiento del cáncer
ECSP19011216A (es) Inhibidores de piridopyrimdinona cdk2/4/6
CR20160518A (es) Compuestos para tratar atrofia muscular espinal
UY36371A (es) Compuestos de indolcarboxamida inhibidores de quinasas tipo btk y tipo tec
BR112017011923A2 (pt) bactéria modificada para tratar doenças associadas com hiperamonemia
UY36126A (es) ?compuestos de 6,8-dioxabiciclo[3.2.1]octano-2,3-diol sustituidos como agentes de direccionamiento al asgpr?.
ECSP20046463A (es) Compuestos, composiciones y métodos para tratar enfermedades que involucren tejidos con enfermedades ácidas o hipóxicas
CO2019005059A2 (es) Inhibidores de magl
CO2019005038A2 (es) Inhibidores de magl
CU20160180A7 (es) Compuestos de dihidroisoquinolinona sustituida
CO6781507A2 (es) Novedosos derivados heterociclicos
GT201400222A (es) Agentes para tratar trastornos que implican la modulación de receptores de rianodina
CO2019009722A2 (es) Dendrímeros terapéuticos
DOP2016000308A (es) Compuestos de 1, 3, 4-tiadiazol y uso de los mismos para el tratamiento del cáncer
CL2021001388A1 (es) Compuestos útiles en la terapia para el vih
CL2021000329A1 (es) Compuestos útiles en terapia del vih
CO2017003305A2 (es) Derivados de la amida del ácido 2-[piridin-3-il]-2,3-dihidro-benzo[1,4]dioxin-5-carboxílico o del 2-[piridin-3-il]-2,3-dihidro-benzo[1,4]dioxin-5-carbonitrilo como inhibidores de aldosterona sintasa
CR11631A (es) Paramyxovirus eficaz como antitumoral
NI201600091A (es) UREAS ASIMÉTRICAS p-SUSTITUIDAS Y USOS MÉDICOS DE LAS MISMAS
CR20170157A (es) Derivados de nucleósidos sustituidos con 4´-vinilo como inhibidores de la replicación del arn del virus respiratorio sincitial
UY36399A (es) Compuestos aromáticos sustituidos y composiciones farmacéuticas para la autoreparación y regeneración del tejido
BR112018012292A2 (pt) compostos e composições tricíclicos como inibidores de cinase
CL2017001390A1 (es) Camkk1 como un nuevo regenerativo terapéutico
ECSP17003149A (es) Compuestos de dihidroisoquinolinona sustituida